Company Number: 13255751

Analysis Date: 2025-07-20 18:24 UTC

1. Industry Classification
   RENE ROUX LIMITED operates within the SIC code 86220, which corresponds to "Specialists medical practice activities." This sector comprises businesses primarily engaged in specialist healthcare services, typically involving medical specialists such as consultants, surgeons, and other sub-specialists working in outpatient or private clinic settings. Key characteristics of this sector include high regulatory oversight, reliance on skilled medical professionals, and a focus on patient care quality and outcomes. The sector often features small to medium-sized practices, many of which function as private limited companies or partnerships.

2. Relative Performance
   As a micro-entity (turnover and balance sheet size below the micro thresholds), RENE ROUX LIMITED is on the smallest end of the spectrum within specialist medical practices. The company’s financials show modest fixed assets (£34k) and current assets (£27k) with current liabilities (£23.9k) and longer-term liabilities (£35.1k) roughly balancing these assets. Net assets are minimal at £491, indicating a thin equity base. Compared to typical industry benchmarks, specialist medical practices—especially established ones—often maintain stronger net asset positions due to stable patient flows and retained earnings. However, many small specialist practices start with minimal capital and gradually build equity through profitability. The company employs only one person (the director), consistent with a very small or sole practitioner operation.

3. Sector Trends Impact
   The specialist medical practice sector in the UK is influenced by several market dynamics:

• Increasing demand for outpatient specialist care driven by NHS waiting list pressures and patient preference for private treatment.
• Regulatory and compliance costs continue to rise, affecting operational margins for small practices.
• Technological adoption such as telemedicine and electronic health records is becoming essential, requiring ongoing investment.
• Private healthcare market competition including from larger clinics and hospital groups poses challenges for micro-entities in attracting patients.
  RENE ROUX LIMITED’s micro scale and current asset/liability balance suggest it may face challenges investing in new technology or scaling operations but could benefit from niche expertise or reputation in its specialist field.

4. Competitive Positioning
   Strengths:

• The company’s small size allows for potentially lower overhead costs and a personalized patient approach, which can be a competitive advantage in the specialist healthcare market.
• Operating as a private limited company provides limited liability protection and potential for future growth or investment.

Weaknesses:

• The minimal net asset base and significant liabilities indicate limited financial cushioning against downturns or unexpected costs, which is riskier compared to more established specialist practices with stronger equity and cash reserves.
• Employing only one individual restricts capacity and service diversification, making it vulnerable to operational disruptions (e.g., if the director is unavailable).
• Limited financial data and absence of profit and loss details constrain deeper profitability analysis, but the thin equity suggests tight margins or reinvestment constraints.

Compared to typical competitors—some of whom may operate as larger partnerships or within hospital groups—RENE ROUX LIMITED is a niche micro-entity potentially relying on specialized expertise rather than scale or broad service offerings.